当前位置: 首页 -> 师资队伍 -> 药学系 -> 正文

梁继超 副教授

作者:

来源:健康科学与工程学院

发布日期:2022年12月29日 12:44

阅读:

一、基本信息

梁继超,副教授,硕士研究生导师,湖北大学药物高通量筛选技术国家地方联合工程研究中心骨干成员。国家公派美国University of Pennsylvania医学院访问学者。武汉海特生物制药股份有限公司科技副总,湖北汇中制药股份有限公司技术副总湖北省森林康养促进会理事,武汉药理学会理事。教育部学位中心全国研究生教育评估监测专家湖北省科技厅生物医药”领域项目评审专家,成都市科学技术局“人口健康”领域项目评审专家,深圳市科技创新局“生物材料”领域项目评审专家Chemical Engineering Journal, Carbohydrate Polymers, International Journal of Biological Macromolecules, Journal of Cellular Biochemistry, International Journal of Nanomedicine, Journal of Biomaterials Applications, Journal of Ethnopharmacology等期刊审稿人。主持国家自然科学基金,湖北省自然科学基金,企业横向课题,大学生创新创业等多项科研项目。以第一作者或通讯作者在Journal of Hepatology, Chemical Engineering Journal, Small, Acta Biomaterialia, Food and Chemical Toxicology等期刊发表SCI论文20余篇,授权中国发明专利4项。

主要研究领域:糖脂代谢稳态调控机制,生物材料设计与应用。

电子邮件:liang529114AT163.com; 20120083AThubu.edu.cn;

二、教育背景及工作经历

2001/9-2005/6 湖北大学,生物工程,学士

2006/9-2012/6 湖北大学/中国医学科学院基础医学研究所联合培养,生物化学与分子生物学博士

2012/7-2014-7 湖北大学,讲师

2014/7至今 湖北大学,副教授

2017/10-2018/10 美国University of Pennsylvania医学院访问学者

三、研究方向:

主要集中于探索2型糖尿病及非酒精性脂肪肝发病机制,寻找新的潜在治疗靶点,并构建相应的药物筛选平台。同时,我们研究传统中药(主要指植物药)活性成分构效关系,揭示其发挥药理作用的潜在分子机制。此外,我们利用学科交叉的思想,基于生物学,化学,材料学等原理,设计生物材料,纳米酶等,探索其在糖尿病创面修复领域的应用,并揭示其潜在作用机制。

四、科研项目

1. 湖北省科技人才服务企业项目(2024DJC075):磷酸奥司他韦胶囊制备工艺过程控制与优化关键技术研究,200万,2024/06-2026/06,项目负责人(科技专员)。

2. 企业横向课题(2024127002001003):磷酸奥司他韦合成路线的改进及药效学评价,40万,2024/04-2025/05,主持。

3. 武当特色中药研究湖北省重点实验室开放基金,重点项目(WDCM2024006):厚朴酚促糖尿病周围神经修复及机制,2万,2024/06-2026/05,主持。

4. 企业横向课题(2022127002001002):体外抗炎药物筛选技术及化合物库构建,400万,2022/04-2025/04,主持。

5. 药物高通量筛选技术国家地方联合工程研究中心自主基金项目(M20202004):原儿茶酸激活AMPK调节肝糖异生,5万,2021/01–2022/12,主持

6. 武当特色中药研究湖北省重点实验室开放课题,面上项目WDCM2019010):原儿茶酸调节肝胰岛素敏感性及机制,1万,2020/072023/06主持

7. 国家自然科学基金青年项目(81400791):MicroRNA-221/222基因簇调节肝胰岛素敏感性及机制研究,23万,2015/01–2017/12,主持

8. 教育部产学合作协同育人项目创新创业联合基金(201601031006):叶酸标记铜纳米簇的合成及其靶向抗乳腺癌的研究,2016第一批,指导教师

9. 湖北省自然科学基金面上项目(ZRY1376):MicroRNA-21调节肝糖脂代谢及机制初探,2013/01–2014/12,主持

10. 湖北省教育厅科学技术研究计划青年人才项目(Q20141002):MicroRNA-22调节肝细胞胰岛素敏感性的研究,2014/01–2015/12,主持

11. 医学分子生物学国家重点实验室开放研究课题(外部课题):MicroRNA-221调节3T3-L1脂肪细胞胰岛素敏感性的研究,2014/01–2015/12,主持

五、代表性论文及授权专利(*通讯作者)

1. Xingyu Wu, Tiantian Feng, Xiaohong Zhu, Dong Dong, Qinxue Gao, Shufan Huang, Rui Huang, Dong Wang, Huayu Xiong, Zigong Wei*, Yong Chen*, Jichao Liang*. Advanced Fe-COF-based photothermal cascade nano-generator for sterilization and promoting wound healing. Chemical Engineering Journal, 2024, 496, 154179. (1TOP,影响因子13.3)

2. Xiaohong Zhu, Tiantian Feng, Yidan Chen, Yao Xiao, Wei Wen, Xiuhua Zhang,

Dong Wang, Shengfu Wang*, Jichao Liang*, Huayu Xiong*. GSH-depleted Cu-covalent organic frameworks for multimodal synergistic therapy against diabetic infections. Chemical Engineering Journal, 2024, 488, 150770. (1TOP,影响因子13.3)

3. Xiaohong Zhu, Tiantian Feng, Yidan Chen, Yan Xiao, Wei Wen, Shengfu Wang,   Dong Wang, Xiuhua Zhang*, Jichao Liang*, Huayu Xiong*. Reactive-Correlated Photothermal Imaging of Smart COF Nanoreactors for Monitoring Chemodynamic Sterilization and Promoting Wound Healing. Small, 2024, e2310247. (1TOP, 影响因子:13.3)

4. Yuan Huang, Bo Huang, Dong Ye, Xinxin Luo, Xilin Xiong, Huayu Xiong, Hangxing Wang, Qichao Zou, Jichao Liang*, Suxiao Wang*, Limin Wu*. Nano-induced endothelial leakiness-reversing nanoparticles for targeting, penetration and restoration of endothelial cell barrier. Acta Biomaterialia, 2024, 175:226-239. (1TOP, 影响因子:9.7)

5. Yidan Chen, Tiantian Feng, Xiaohong Zhu, Yuting Tang, Yao Xiao, Xiuhua Zhang, Sheng-Fu Wang, Dong Wang, Wei Wen*, Jichao Liang*, and Huayu Xiong*. Ambient Synthesis of Porphyrin-Based Fe-Covalent Organic Frameworks for Efficient Infected Skin Wound Healing. Biomacromolecules, 2024, 25, 6, 3671-3684. (1TOP, 影响因子:5.5)

6. Chen Ye, Wen Jiang, Ting Hu, Jichao Liang*, Yong Chen*. The regulatory impact of CFLAR methylation modification on liver lipid metabolism. International Journal of Molecular Sciences, 2024, 25(14):7897. (2, 影响因子:4.9)

7. 黄舒凡,熊华玉*梁继超*. 交叉学科人才培养新模式探索. 创新教育研究. 2024, 12(1), 148-152.

8. Dong Dong, Zihao Cheng, Tongyao Wang, Xingyu Wu, Chang Ding, Yong Chen*, Huayu Xiong*, Jichao Liang*. Acid-degradable nanocomposite hydrogel and glucose oxidase combination for killing bacterial with photothermal augmented chemodynamic therapy. International Journal of Biological Macromolecules, 2023, 234, 123745. (1TOP,影响因子:8.2)

9. Man Hu, Wen Jiang, Chen Ye, Ting Hu, Qingqing Yu, Moran Meng, Lijuan Sun, Jichao Liang*, Yong Chen*. Honokiol attenuates high glucose-induced peripheral neuropathy via inhibiting ferroptosis and activating AMPK/SIRT1/PGC-1ɑ pathway in Schwann cells. Phytotherapy Research, 2023, advance online publication. https://doi.org/10.1002/ptr.7984. (2区,影响因子:7.2)

10. Wen Jiang, Ting Hu, Chen Ye, Man Hu, Qingqing Yu, Lijuan Sun, Jichao Liang*, Yong Chen*. Formononetin attenuates high glucose-induced neurotoxicity by negatively regulating oxidative stress and mitochondrial dysfunction in Schwann cells via activation of SIRT3. Food and Chemical Toxicology, Accepted 26 October 2023. (1TOP,影响因子:4.3)

11. Tongyao Wang, Dong Dong, Tong Chen, Junlun Zhu, Suxiao Wang, Wei Wen, Xiuhua Zhang, Huadong Tang, Jichao Liang*, Shengfu Wang*, Huayu Xiong*. Acidity-responsive cascade nanoreactor based on metal-nanozyme and glucose oxidase combination for starving and photothermal-enhanced chemodynamic antibacterial therapy. Chemical Engineering Journal, 2022, 446,3,137172. (1TOP影响因子:16.7)

12. Cun Deng, Dong Dong, Tongyao Wang, Man Hu, Lijuan Sun, Xiuhua Zhang, Shengfu Wang, Huayu Xiong*, Yong Chen*, Jichao Liang*. Promotion of diabetic wound healing using novel Cu2O/Pt nanocubes through bacterial killing and enhanced angiogenesis in rats. Materials Science & Engineering C-Materials for Biological Applications, 2022, 134:112552.(1TOP,影响因子:8.4)

13. Xueyun Liu, Man Hu, Chen Ye, Lihong Liao, Chang Ding, Lijuan Sun, Jichao Liang*, Yong Chen*. Isosilybin regulates lipogenesis and fatty acid oxidation via the AMPK/SREBP-1c/PPARα pathway, Chemico-Biological Interactions, 2022, 110250. (2区,影响因子:5.1)

14. Jichao Liang, Huayu Xiong, Wei Wang, Wei Wen, Xiuhua Zhang, ShengfuWang*. “Luminescent-off/on” sensing mechanism of antibiotic-capped gold nanoclusters to phosphate-containing metabolites and its antibacterial characteristics. Sensors and Actuators B: Chemical, 2018, 255, 2170-2178. (1TOP,影响因子:6.3)

15. Chunyuan Du, Haibo Yan, Jichao Liang*, Ailing Luo, Lingqian Wang, Jing Zhu, Huayu Xiong, Yong Chen*. Polyethyleneimine-capped silver nanoclusters for microRNA oligonucleotide delivery and bacterial inhibition. International Journal of Nanomedicine, 2017, 12, 8599-8613. (2TOP,影响因子:4.3)

16. Jichao Liang, Changzheng Liu, Aijun Qiao, Ying Cui, Huabing Zhang, Anfang Cui, Shutian Zhang, Yanli Yang, Xinhua Xiao, Yong Chen*, Fude Fang*, Yongsheng Chang*. MicroRNA-29a-c decrease fasting blood glucose levels by negatively regulating hepatic gluconeogenesis. Journal of Hepatology, 2013, 58 (3):535-542. (1TOP,影响因子:9.8)

17. Aijun Qiao, Jichao Liang, Yaojun Ke, Chenghong Li, Ying Cui, Lian Shen, Huabing Zhang, Anfang Cui, Xiaojun Liu, Changzheng Liu, Yong Chen, Yi Zhu, Youfei Guan, Fude Fang*, Yongsheng Chang*. Mouse patatin-like phospholipase domain-containing 3 influences systemic lipid and glucose homeostasis. Hepatology, 2011, 54(2):509-521. (1TOP,影响因子:10.4)

18. Jichao Liang, Fengmei Han, Yong Chen*. An electrochemical method for high sensitive detection of nicotine and its interaction with bovine serum albumin. Electrochemistry Communications, 2012, 24:93-96.

19. Yayun Liu, Jichao Liang*, Qiuju Wang, Yu He, Yong Chen*. Copper nanoclusters trigger muscle cell apoptosis and atrophy in vitro and in vivo. Journal of Applied Toxicology, 2016, 36(3):454-463.

20. Ailing Luo, Haibo Yan, Jichao Liang*, Chunyuan Du, Xuemei Zhao, Lijuan Sun, Yong Chen*. MicroRNA-21 regulates hepatic glucose metabolism by targeting FOXO1. Gene, 2017, 627:194-201.

21. 一种抑制hsa-miR-221-3p的寡核苷酸序列、重组腺病毒及其制备方法和应用. 梁继超,骆爱玲,杜春园,孙丽娟,陈勇. 专利号:ZL201610137218.0

22. 一种对pH敏感的荧光纳米铜簇凝胶的制备方法. 梁继超,王薇,熊华玉,王升富,文为,张修华,马志刚. 专利号:ZL201610109104.5

23. 一种检测核酸外切酶I活性的探针及其制备方法和应用. 梁继超,熊华玉,宋佳宜,杜春园. 专利号:ZL201810178752.5

24. 一种纳米材料的制备及其基因载体系统的制备方法. 梁继超,熊华玉,杜春园,陈勇. 专利号:ZL201710102510.3

六、获得奖励

1. 湖北大学科研突出贡献奖。梁继超2024

2. 湖北大学“好老师就在我身边”入选者。梁继超2024

3. 年度工作突出贡献/事业单位工作人员嘉奖证书。梁继超2024

4. 年度工作突出贡献/事业单位工作人员嘉奖证书。梁继超2022

5. 肝糖脂代谢稳态调控新机制。陈勇,梁继超,韩凤梅,王俊俊,湖北省自然科学三等奖,2020

6. MicroRNA-29a-c对小鼠血糖水平的调节及机制研究。梁继超,湖北省优秀博士学位论文,2013